文献速递湿疹皮炎与荨麻疹

度普利尤单抗治疗特应性皮炎后头颈部矛盾性红斑的临床与组织病理学特征

Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series.
PubMed 文献 · Br J Dermatol · 2019-12-22

本文报告7例特应性皮炎患者在接受度普利尤单抗治疗后10–39周出现头颈部矛盾性红斑,表现为边界较清晰、斑片状红斑,鳞屑较原有湿疹少或无。仅1例有瘙痒和灼烧感但与既往面部AD不同,6例其他部位湿疹明显改善,平均治疗满意度NRS为9/10。局部和系统治疗无效,但无患者停药;活检示毛细血管扩张、血管周围淋巴组织细胞浸润,4例表皮增生伴钉突延长呈银屑病样皮炎,免疫组化示浆细胞、组织细胞和T淋巴细胞增多,海绵水肿基本缺失。

要点

  • 度普利尤单抗治疗AD后10–39周可出现头颈部矛盾性红斑,需识别。
  • 红斑鳞屑少或无,仅少数有瘙痒灼烧,其他部位湿疹多明显改善。
  • 活检示毛细血管扩张和血管周围淋巴组织细胞浸润,部分呈银屑病样。

核心结论

  • 度普利尤单抗治疗AD后可出现头颈部矛盾性红斑,临床和组织病理学呈异质性反应,最提示药物诱导性皮肤反应。

研究设计与样本

  • 病例系列,报告7例接受度普利尤单抗治疗的特应性皮炎患者。

主要发现

  • 7例患者在度普利尤单抗开始后10–39周出现头颈部矛盾性红斑。
  • 仅1例有瘙痒和灼烧感,但与既往面部AD明显不同。
  • 6/7例其他部位湿疹明显改善,活检时平均治疗满意度NRS为9/10。
  • 局部和系统药物治疗红斑均无效,但无患者停用度普利尤单抗。
  • 活检示所有患者毛细血管扩张和血管周围淋巴组织细胞浸润,4例表皮增生伴钉突延长呈银屑病样皮炎,海绵水肿基本缺失。

关键数值与推荐

  • 红斑出现时间为度普利尤单抗开始后10–39周。
  • 平均治疗满意度NRS为9/10(活检时)。
  • 免疫组化示浆细胞、组织细胞和T淋巴细胞增多。

临床怎么用

  • 对度普利尤单抗治疗AD后出现头颈部红斑者,应结合临床和组织病理学评估矛盾反应。
  • 尽管红斑对局部和系统治疗无效,但其他部位湿疹改善且患者未停药,可考虑继续治疗并管理红斑。

局限性

  • 样本量小(7例),为病例系列,证据级别有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dupilumab is the first biologic registered for the treatment of atopic dermatitis (AD). We report on seven patients with AD presenting with a paradoxical head and neck erythema that appeared 10-39 weeks after the start of dupilumab treatment. The patients presented with a relatively sharply demarcated, patchy erythema in the head and neck area that showed no or less scaling compared with their usual eczema. Only one patient experienced symptoms of itch and burning, although this was notably different from his pre-existent facial AD. Except for a notable 'red face', eczema on other body parts had greatly improved in six of the seven patients, with a mean numerical rating scale for treatment satisfaction of 9 out of 10 at the time of biopsy. Treatment of the erythema with topical and systemic drugs was unsuccessful. Despite the presence of this erythema, none of our patients discontinued dupilumab treatment. Lesional skin biopsies showed an increased number of ectatic capillaries, and a perivascular lymphohistiocytic infiltration in all patients. In addition, epidermal hyperplasia with elongation of the rete ridges was observed in four patients, resembling a psoriasiform dermatitis. Additional immunohistochemical stainings revealed increased numbers of plasma cells, histiocytes and T lymphocytes. Interestingly, spongiosis was largely absent in all biopsies. We report on patients with AD treated with dupilumab developing a paradoxical erythema in a head and neck distribution. Both clinically and histopathologically we found a heterogeneous response, which was most suggestive of a drug-induced skin reaction.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. de Wijs LEM, Nguyen NT, Kunkeler ACM, et al. Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series. Br J Dermatol. 2019. PMID: 31749159. doi:10.1111/bjd.18730

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。